Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. STKE, 14 August 2007
Vol. 2007, Issue 399, p. tw294
[DOI: 10.1126/stke.3992007tw294]

EDITORS' CHOICE

Immunology Making IL-33 Less Complex

John F. Foley

Science’s STKE, AAAS, Washington, DC 20005, USA

Interleukin-33 (IL-33), a member of the IL-1 family of cytokines, mediates its effects through a heterodimer consisting of ST2L and an as-yet-unidentified second receptor. IL-33 stimulates the production of cytokines associated with a T helper 2 (Th2) response, including IL-5 and IL-13. ST2L is homologous to the ligand-binding subunits of the receptors for the IL-1 family members IL-1 and IL-18. Some members of the IL-1 family use the second component of the IL-1 receptor (IL-1R) complex, the IL-1R accessory protein (IL-1RAcP), so Chackerian et al. investigated whether IL-1RAcP was the second component of the IL-33R complex. The administration of recombinant IL-33 to wild-type mice resulted, as expected, in a systemic inflammatory response, as measured by immunohistochemical analysis of the small intestine and quantification of serum levels of IL-5 (and other cytokines) by enzyme-linked immunosorbent assay (ELISA). However, none of these effects were observed in IL-33-treated mice that were deficient in IL-1RAcP (IL-1RAcP KO mice). Real-time reverse transcription polymerase chain reaction (RT-PCR) assays demonstrated the increased abundance of mRNAs for proinflammatory cytokines in the lungs of IL-33-treated wild-type mice compared with those of IL-1RAcP KO mice. Whereas CD4+ T cells from wild-type and IL-1RAcP KO mice could be activated under Th2-polarizing conditions in vitro, only wild-type cells responded to IL-33 treatment to enhance secretion of IL-5 and IL-13. The authors used ELISA to detect the binding of soluble IL-33 and epitope-tagged IL-1RAcP to plate-bound ST2. IL-33R signaling results in the activation of the transcription factor nuclear factor {kappa}B (NF-{kappa}B). This activation depends on the adaptor protein MyD88, which contains a Toll-IL-1R (TIR) domain, as does IL-1RAcP. IL-33 treatment of a cell line expressing ST2L and a truncated IL-1RAcP (missing the TIR domain) resulted in less activation of NF-{kappa}B than did IL-33 treatment of cells expressing ST2L with wild-type IL-1RAcP, as assessed by fluorescence-based reporter assays. In a related study, Allakhverdi et al. examined the effects of IL-33 on mast cells, which express ST2. Treatment of human mast cells with IL-33 resulted in the secretion of proinflammatory chemokines and cytokines. Mast cells are derived from CD34+ progenitor cells, which can be activated by thymic stromal lymphopoietin (TSLP). The authors found that IL-33, either alone or in combination with TSLP, induced the maturation of CD34+ cells into mast cells. Mast cells are important in allergic responses, which are often characterized by the presence of Th2-associated cytokines, so the action of IL-33, a Th2-promoting cytokine, on mast cells may have clinical relevance. Together, these studies provide new insights into the role and mechanism of IL-33 signaling and may have implications for other members of the IL-1 family that use IL-1RAcP and for understanding the contributions of mast cells to Th2 immune responses.

A. A. Chackerian, E. R. Oldham, E. E. Murphy, J. Schmitz, S. Pflanz, R. A. Kastelein, IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J. Immunol. 179, 2551-2555 (2007). [PubMed]

Z. Allakhverdi, D. E. Smith, M. R. Comeau, G. Delespesse, Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J. Immunol. 179, 2051-2054 (2007). [PubMed]

Citation: J. F. Foley, Making IL-33 Less Complex. Sci. STKE 2007, tw294 (2007).



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882